Vendor, Milton, GA
Zeeva Therapeutics Corporation
UEI T34KC4MBX7B5, CAGE 9QPF9
1 award and $742,100 obligated between April 16, 2024 and May 2, 2025, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $742,100 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $742,100 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50124C00004Definitive Contract, April 16, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Zeeva Therapeutics Corporation - Research and Development Aoi #19 for the Development of a Novel Tube Junction Connector for Blood Circuits NAICS 541714, PSC AN13 | $742,100 |
- Places of performance
- Georgia
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 4 across 1 awards